Causes of Death and Comorbidities in Patients with COVID-19

Sefer Elezkurtaj; Selina Greuel; Jana Ihlow; Edward Michaelis; Philip Bischoff; Catarina Alisa Kunze; Bruno Valentin Sinn; Manuela Gerhold; Kathrin Hauptmann; Barbara Ingold-Heppner; Florian Miller; Hermann Herbst; Victor Max Corman; Hubert Martin; Frank L Heppner; David Horst.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-20131540

Documentos relacionados

  1. Causes of death and comorbidities in hospitalized patients with COVID-19.
  2. Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19.
  3. SARS-CoV-2 cellular tropism and direct multiorgan failure in COVID-19 patients: Bioinformatic predictions, experimental observations, and open questions.
  4. Drug repurposing for the treatment of COVID-19.
  5. Inhaled corticosteroids for the treatment of COVID-19.
  6. Monoclonal antibody therapy in COVID-19.
  7. Natural products as home-based prophylactic and symptom management agents in the setting of COVID-19.
  8. In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs.
  9. Treatment of respiratory viral infections through inhalation therapeutics: Challenges and opportunities.
  10. COVID-19: Inflammatory Profile.